Clinical Trials Directory

Trials / Terminated

TerminatedNCT00157846

X-Change HF - Exchange of the Existing Pacemaker/ICD in Bradycardia Patients Suffering From Heart Failure

Exchange of the Existing Pacemaker/ICD in Bradycardia Patients Suffering From Heart Failure to Investigate the Effect of Preventive Stimulation

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
36 (actual)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of X-Change HF is to estimate the effect of biventricular stimulation in patients who need antibradycardia ventricular stimulation (more than 80%); are eligible for the exchange of an old pacemaker or implantable cardioverter defibrillator (ICD); and have ventricular dysfunction (left ventricular ejection fraction \[LVEF\] \< 35%). All patients eligible for participation in the study will be upgraded with a cardiac resynchronization therapy (CRT)-device and receive either right ventricular or biventricular stimulation in a crossover protocol. The endpoint is functional performance measured by spiroergometry.

Conditions

Interventions

TypeNameDescription
DEVICECRT-P or CRT-D DeviceUpgrade from ICD or pacemaker to CRT-D/CRT-P (Insync III, Insync Marquis, Insync Sentry, Insync Maximo, Concerto)

Timeline

Start date
2003-10-01
Primary completion
2008-08-01
Completion
2008-08-01
First posted
2005-09-12
Last updated
2025-07-03

Locations

10 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT00157846. Inclusion in this directory is not an endorsement.